251 related articles for article (PubMed ID: 32304400)
1. Opioid analgesia: recent developments.
Stein C
Curr Opin Support Palliat Care; 2020 Jun; 14(2):112-117. PubMed ID: 32304400
[TBL] [Abstract][Full Text] [Related]
2. New concepts in opioid analgesia.
Stein C
Expert Opin Investig Drugs; 2018 Oct; 27(10):765-775. PubMed ID: 30148648
[TBL] [Abstract][Full Text] [Related]
3. [Pain inhibition by opioids-new concepts].
Stein C
Anaesthesist; 2019 Feb; 68(2):97-103. PubMed ID: 30645691
[TBL] [Abstract][Full Text] [Related]
4. [Pain inhibition by opioids-new concepts].
Stein C
Schmerz; 2019 Aug; 33(4):295-302. PubMed ID: 31222410
[TBL] [Abstract][Full Text] [Related]
5. Opioid Receptors.
Stein C
Annu Rev Med; 2016; 67():433-51. PubMed ID: 26332001
[TBL] [Abstract][Full Text] [Related]
6. Pain therapy - Are there new options on the horizon?
Stein C; Kopf A
Best Pract Res Clin Rheumatol; 2019 Jun; 33(3):101420. PubMed ID: 31703793
[TBL] [Abstract][Full Text] [Related]
7. Imaging opioid analgesia in the human brain and its potential relevance for understanding opioid use in chronic pain.
Lee MC; Wanigasekera V; Tracey I
Neuropharmacology; 2014 Sep; 84(100):123-30. PubMed ID: 23891639
[TBL] [Abstract][Full Text] [Related]
8. Replacement of current opioid drugs focusing on MOR-related strategies.
Busserolles J; Lolignier S; Kerckhove N; Bertin C; Authier N; Eschalier A
Pharmacol Ther; 2020 Jun; 210():107519. PubMed ID: 32165137
[TBL] [Abstract][Full Text] [Related]
9. Opioids, sensory systems and chronic pain.
Stein C
Eur J Pharmacol; 2013 Sep; 716(1-3):179-87. PubMed ID: 23500206
[TBL] [Abstract][Full Text] [Related]
10. Mitigation of IV Abuse Through the Use of Abuse-Deterrent Opioid Formulations: An Overview of Current Technologies.
Rauck RL
Pain Pract; 2019 Apr; 19(4):443-454. PubMed ID: 30597739
[TBL] [Abstract][Full Text] [Related]
11. Opioids with abuse-deterrent properties: A regulatory and technological overview.
Haddox JD
J Opioid Manag; 2017; 13(6):397-413. PubMed ID: 29308587
[TBL] [Abstract][Full Text] [Related]
12. [Development of opioid tolerance -- molecular mechanisms and clinical consequences].
Freye E; Latasch L
Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):14-26. PubMed ID: 12522725
[TBL] [Abstract][Full Text] [Related]
13. Opioid Abuse in Chronic Pain--Misconceptions and Mitigation Strategies.
Volkow ND; McLellan AT
N Engl J Med; 2016 Mar; 374(13):1253-63. PubMed ID: 27028915
[No Abstract] [Full Text] [Related]
14. Addressing opioid tolerance and opioid-induced hypersensitivity: Recent developments and future therapeutic strategies.
Khan F; Mehan A
Pharmacol Res Perspect; 2021 May; 9(3):e00789. PubMed ID: 34096178
[TBL] [Abstract][Full Text] [Related]
15. The opioid crisis: a 21st century pain.
Walker G
Drugs Today (Barc); 2018 Apr; 54(4):283-286. PubMed ID: 29869649
[TBL] [Abstract][Full Text] [Related]
16. Impact of Abuse Deterrent Formulations of Opioids in Patients With Chronic Pain in the United States: A Cost-Effectiveness Model.
Kumar VM; Agboola F; Synnott PG; Segel C; Webb M; Ollendorf DA; Banken R; Chapman RH
Value Health; 2019 Apr; 22(4):416-422. PubMed ID: 30975392
[TBL] [Abstract][Full Text] [Related]
17. Combining opioids and non-opioids for pain management: Current status.
Li JX
Neuropharmacology; 2019 Nov; 158():107619. PubMed ID: 31029588
[TBL] [Abstract][Full Text] [Related]
18. Opioid addiction, diversion, and abuse in chronic and cancer pain.
Kata V; Novitch MB; Jones MR; Anyama BO; Helander EM; Kaye AD
Curr Opin Support Palliat Care; 2018 Jun; 12(2):124-130. PubMed ID: 29465470
[TBL] [Abstract][Full Text] [Related]
19. Abuse-deterrent formulations of prescription opioid analgesics in the management of chronic noncancer pain.
Hale ME; Moe D; Bond M; Gasior M; Malamut R
Pain Manag; 2016 Oct; 6(5):497-508. PubMed ID: 27050830
[TBL] [Abstract][Full Text] [Related]
20. Opioid analgesia: perspectives on right use and utility.
Ballantyne JC
Pain Physician; 2007 May; 10(3):479-91. PubMed ID: 17525783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
